Zullo Investment Group, Inc. Gilead Sciences, Inc. Transaction History

Zullo Investment Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $1,744 - $2,505	28 Added 4.25%	687 $58,000
Q3 2022 Nov 08, 2022	BUY	$59.54 - $68.01 $2,024 - $2,312	34 Added 5.44%	659 $41,000
Q2 2022 Aug 11, 2022	BUY	$57.72 - $65.01 $8,600 - $9,686	149 Added 31.3%	625 $39,000
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $26,237 - $32,878	453 Added 1969.57%	476 $28,000
Q4 2021 Feb 16, 2022	BUY	$64.88 - $73.64 $1,492 - $1,693	23 New	23 $2,000

1,931

991M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Zullo Investment Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Zullo Investment Group, Inc. with notifications on news.